Former Chief Medical Officer · Opus Genetics, Inc. (IRD)

Ely Benaim

A named executive officer of Opus Genetics in every fiscal year CompBrief holds from FY2017 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$245,029

Salary $110,000Stock awards $0Bonus $88,000

FY2018: $851,361

3rd of 3 named executive officers at Opus Genetics by FY2019 total.

3 named officers on file for Opus Genetics, FY2019

Ely Benaim’s pay file — $29

  • 3 fiscal years of pay, line by line
  • IRD’s disclosed peer group of 10 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Opus Genetics’s whole pay program stands against its peers

  • Opus Genetics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IRD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2020 (10-K).

Free

Get Ely Benaim’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Ely Benaim compensation by year

Opus Genetics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Opus Genetics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019
Salary$400,000$440,000$110,000
Bonus$0$0$88,000
Stock awards$17,480$0$0
Option awards$51,987$294,861$41,254
Non-equity incentive$136,000$100,000$0
Pension and deferred compensation$0$0$0
All other$16,300$16,500$5,775
Total$621,767$851,361$245,029

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Opus Genetics, Inc. 10-K filed April 29, 2020, accession 0001140361-20-010048, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Opus Genetics, Inc. filed document, accession 0001140361-20-010048. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2020.

$622K
$851K
$245K
FY17
FY18
FY19
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
RSU594$6,629—
Option417—$85.20
Option1,129—$42.00
Option1,954—$22.08
Option3,786—$27.48
Option16,666—$21.36

Per the Outstanding Equity Awards at Fiscal Year-End table in Opus Genetics, Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Opus Genetics’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Douglas SwirskyPresident and Chief Executive Officer$650,677
Lisa NolanFormer Chief Business Officer$375,686
Ely Benaim · this pageFormer Chief Medical Officer$245,029

The full Opus Genetics compensation record

free company brief

This page is one person within Opus Genetics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Opus Genetics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Opus Genetics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Ely Benaim's compensation dossier · One-time report. No refunds.